NVAX Stock – Businesses scramble for vaccines to use in private scheme – National
After receiving approval from the Health Ministry, businesses are scrambling to secure vaccines from several producers as part of a private vaccination scheme, even though observers have urged the government to procure the doses itself.
The Health Ministry recently issued a ministerial regulation on the technicalities of the private vaccination scheme, dubbed the Gotong Royong Vaccination Program, which will allow business owners to buy their own vaccine supplies for their employees.
The regulation prohibits them from using the same vaccine used in the government’s inoculation program, CoronaVac from Chinese firm Sinovac Biotech Ltd, and vaccines produced by United States-based Novavax and Pfizer, as well as British firm AstraZeneca.
The Indonesian Chamber of Commerce and Industry (Kadin) said the business association was eyeing vaccines produced by the state-backed China …